Overview
Ray Therapeutics, a Berkeley, CA-based biopharmaceutical company developing new optogenetic gene therapies to restore vision, received an $8M grant from the California Institute for Regenerative Medicine (CIRM). The company intends to use the funds to advance the ongoing Phase 1/2 clinical trial and manufacturing activities for RTx-021 in the treatment of Stargardt disease....See more
Website
https://www.raytherapeutics.com/Headquarters
Berkeley, CA
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$8.0M • Grant
Announced on 9/30/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.